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Abstract
Background: General medical hospitals provide care for a disproportionate share of patients who abuse or are
dependent upon substances. This group is among the most costly to treat and has the poorest medical and
addiction recovery outcomes. Hospitalization provides a unique opportunity to identify and motivate patients to
address their substance use problems in that patients are accessible, have time for an intervention, and are often
admitted for complications related to substance use that renders hospitalization a “teachable moment.”
Methods/Design: This randomized controlled trial will examine the effectiveness of three different strategies
for integrating motivational interviewing (MI) into the practice of providers working within a general medical
inpatient hospitalist service: (1) a continuing medical education workshop that provides background and
“shows” providers how to conduct MI (See One); (2) an apprenticeship model involving workshop training
plus live supervision of bedside practice (Do One); and (3) ordering MI from the psychiatry consultation-liaison
(CL) service after learning about it in a workshop (Order One). Thirty providers (physicians, physician assistants,
nurses) will be randomized to conditions and then assessed for their provision of MI to 40 study-eligible
inpatients. The primary aims of the study are to assess (1) the utilization of MI in each condition; (2) the
integrity of MI when providers use it on the medical units; and (3) the relative costs and cost-effectiveness
of the three different implementation strategies.
Discussion: If implementation of Do One and Order One is successful, the field will have two alternative
strategies for supporting medical providers’ proficient use of brief behavioral interventions, such as MI, for
medical inpatients who use substances problematically.
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Background
Individuals who use substances are seven times more
likely than non-substance-using individuals to be admit-
ted to a hospital for medical care secondary to complica-
tions that are caused by their substance use [1]. Between
20 and 36 % of hospitalized patients are current smokers
[2–4] and 10–40 % have an alcohol or drug use disorder
[5–9], with high rates of co-occurrence among substance
use disorders [2]. These rates far exceed those found in
the general US population [10], demonstrating that in-
patient hospitals provide care for a disproportionate
share of patients who misuse substances [11]. These pa-
tients are costly to treat and at risk for poor health out-
comes [12, 13]. Hospitalization provides a unique
opportunity to identify and motivate patients to address
their substance use problems in that patients are access-
ible, have time for an intervention, and are often admitted
for complications related to substance use that renders
hospitalization a “teachable moment” [14, 15].
Motivational interviewing for substance use disorders
Motivational interviewing (MI) [16, 17] has been the
basis of most brief behavioral interventions used in med-
ical settings [18]. MI is a patient-centered approach that
develops the patients’ motivation and commitment to
change within a collaborative, highly empathic patient-
clinician relationship. Clinicians blend a combination of
fundamental patient-centered counseling skills (e.g., re-
flective listening) with advanced strategic methods (e.g.,
develop discrepancies between important life goals and
substance use) to elicit and support patient statements
that favor change (i.e., change talk) and decrease those
against change (i.e., sustain talk). The aim is to have pa-
tients talk themselves into behavioral change.
MI has a strong evidence base in the treatment of
substance use disorders (alcohol, drugs, nicotine), con-
sistently demonstrating small to moderate clinically sig-
nificant effects across targeted behaviors [19, 20]. As a
brief intervention for primary care patients, MI has its
most consistent support with non-dependent unhealthy
alcohol use [21–25]. Some studies suggest that MI is
more effective than expected with dependent drinkers
in hospitals and other medical settings [26–28], as well
as with younger adult, female, and alcohol-misusing
medical inpatients [29]. MI also has promise for ad-
dressing medical patients’ illicit drug use [30, 31],
though recent studies indicate that more evidence for
its effectiveness in this arena is needed [32, 33]. In
addition, MI’s key causal model of affecting patient
language for and against change has been generally
supported [34–38]. Miller and colleagues [17, 39] rec-
ommend the strength and frequency of in-session client
change talk and sustain talk as good proxies for patient
outcomes.
MI skills can be taught to a broad range of health care
providers [40], with training gains that are medium to large
[41, 42]. One-time workshop training has been the main
strategy for teaching clinicians MI, especially in healthcare
where formal continuing medical education (CME) events
such as workshops are common [40, 43, 44]. MI workshop
training alone consistently produces immediate increases
in MI integrity (i.e., adherence and competence); however,
without subsequent post-workshop training, these gains
erode [41, 42, 45]. In contrast, when a workshop is
followed by a competency-based supervision approach
marked by direct observation of practice, MI integrity
rating-based feedback, and coaching-specific MI practices,
initial skill gains are sustained [41, 42].
Implementing post-workshop feedback/coaching strategies
within medical settings
Integration of substance use interventions into medical
settings could improve health outcomes and reduce health
care costs [24, 25, 31, 46, 47]. However, this is contingent
upon effective implementation strategies. Implementation
theories identify two important components for consider-
ation when crafting strategies: complexity and compatibil-
ity. The more complex a strategy, the greater the difficulty
in implementation [48–51]. Similarly, if a strategy is not
compatible with the setting’s existing workflows and sys-
tems, implementation is likely to fail [48, 49, 51, 52]. In
short, implementation strategies that are straightforward
and fit into existing practices of medical providers and
their workplaces are most likely to succeed [53].
Traditionally, an apprenticeship model has been used
to instruct inpatient medical providers in bedside proce-
dures [54–57], but this model has not been applied to
promote the use of behavioral counseling techniques.
Commonly referred to as “see one, do one,” the in-
structor explains the theory and techniques of a practice
and demonstrates it in a simulated scenario or directly
with patients. Subsequently, trainees practice the ap-
proach under the supervision of an expert provider who
offers live performance feedback and coaching to im-
prove the technique. This form of learning on the job
has been a modus operandi in medical education for
centuries [57] and is analogous to the competency-based
supervision approach noted above. The ultimate aim of
“see one, do one” is to have clinicians implement the
procedure proficiently with their patients. One potential
caveat to “see one, do one” is that it is somewhat com-
plex because it requires appropriate patients and a
trainer available for teaching. Moreover, when applied to
behavioral counseling approaches like MI, it may be seen
as incompatible with the clinicians’ medical role and
time constraints [18].
Another common practice in general hospitals is the
use of psychiatry consultation-liaison (CL) services. CL
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providers who are expert in a particular subspecialty of
medicine, such as mental health and addiction problems
[58], provide assessment and specialty guidance on the
management of patients. Inpatient clinicians request a
CL consult by ordering it through the electronic medical
record, which is provided on the same day or day there-
after, depending on the urgency of the request. About
20 % of psychiatric CL consultations involve patients
who have substance use problems [59–64]. The ultimate
aim of CL is to have highly trained specialists implement
the procedure proficiently with patients, rather than hav-
ing the referring clinicians conduct it themselves. The
use of CL as a promising vehicle for implementing spe-
cialized behavioral counseling approaches such as MI in
inpatient medicine has never been tested. From the per-
spective of inpatient clinicians, using CL is a simple,
minimally burdensome process (i.e., order one) and
highly compatible with the way they secure other spe-
cialist services for their patients. The potential problems
with this approach are as follows: (1) it requires clini-
cians to recognize and order the service; (2) patients
must accede to a consultation with a substance abuse
expert; (3) it may be more expensive since it requires
additional staff time from individuals who have expert
training and work on a specialty service; and (4) the
treatment would be delivered by providers who are not
central to the overall care of the patient, thus potentially
reducing the potency of the intervention. Given the pos-
sible pros and cons of these approaches, we currently
lack information about the most effective and cost-
effective strategies by which to implement MI into a
general inpatient medical setting.
Study focus and aims
This study will examine the effectiveness of three differ-
ent strategies for integrating MI into the practice of
medical providers (nurses, physician assistants (PA),
physicians) working within a general medical hospitalist
service at a large, academically affiliated teaching hos-
pital in Connecticut. We will randomize 30 providers to
one of three conditions: (1) a continuing medical educa-
tion workshop that “shows” providers how to conduct
MI (the control condition, called See One); (2) a “see
one, do one” apprenticeship model involving workshop
training plus live supervision of bedside practice (Do
One); and (3) ordering MI from CL after learning about
it in a workshop (Order One). Following the respective
MI trainings, each provider will be assessed for the
provision of MI to 40 study-eligible inpatients, recruited
by the research team after admission to the general
medical units.
Our primary aims are to assess the uptake of MI by
providers, the integrity by which they use MI, and the
cost-effectiveness of the three implementation strategies.
We hypothesize that the percentage of MI interviews in
study-eligible inpatients per provider will be higher in
both the Do One and Order One groups than the See
One group. We also hypothesize that both the Do One
and Order One groups will conduct sessions with
greater MI adherence and competence than the See One
group. Finally, we predict that See One will be the most
cost-effective implementation strategy when the thresh-
old monetary value to hospital decisionmakers is rela-
tively low for more inpatients to receive an adequately
conducted MI session, whereas Do One and Order One
will be more cost-effective than See One when the
threshold value is relatively high.
Methods/Design
Study design and overview
This study is a hybrid type 3 effectiveness-implementation
trial [65] in that it primarily will evaluate the effectiveness
of three different implementation strategies for integrating
MI into a general medical hospitalist service, and second-
arily examine proximal patient-level effects of MI in the
form of in-session frequency and strength of patient
change talk and sustain talk. Specifically, providers will be
randomized to one of three conditions (See One, Do One,
or Order One) and followed for their provision of MI to
study-eligible/consented patients. Research staff also will
recruit patients who are admitted to the general medical
hospitalist service and assigned to a participating provider
according to the hospital’s usual clinical administrative
procedures. Thus, patients will follow the randomization
condition of their provider, though providers will not
know which patients on their caseloads have enrolled in
the study. This approach will permit a naturalistic test of
the providers’ ability to identify and intervene using MI
with patients who have substance use problems. Each pro-
vider will be followed until he or she has cared for 40
study-enrolled patients, whether or not the provider has
recognized the patient as a substance user and/or pro-
vided a MI intervention. Research staff will not tell the
providers the target enrollment but rather will tell them
when they have reached the “target” number and have
completed the trial. In total, 1200 medical inpatients will
be enrolled and may potentially receive a MI intervention.
Post-trial, providers will participate in a qualitative inter-
view that will determine implementation facilitators and
barriers.
Primary outcomes will be (1) the percentage of MI ses-
sions, as verified by audio recordings, conducted among
each provider’s 40 consecutively enrolled study patients;
(2) independently rated MI adherence and competence
ratings of the sessions; and (3) the percentage of sessions
conducted that meet a criterion level of adequate MI
performance used in MI effectiveness [66–68] and clin-
ician training trials [69, 70]. In addition, we will calculate
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the relative costs and cost-effectiveness of the three con-
ditions. Secondary outcomes will be (1) independently
rated strength and frequency of patient statements that
favor (change talk) or disfavor change (sustain talk) in
the sessions as a proxy for patient outcomes [17, 39],
and (2) themes related to implementation facilitators
and barriers identified through qualitative interviews.
Setting
The proposed study is taking place on the general med-
ical units of a university-affiliated teaching hospital. The
general medical hospitalist service consists of PA and
MD teams who share care of approximately eight med-
ical inpatients daily. Providers typically see patients on
more than one unit and see each assigned patient once
or twice per day. The general internal medicine hospital-
ist teams cover about 160 beds/day (range = 130–210)
on 13 different units, excluding intensive care units. In
2014, the service was responsible for approximately
10,000 discharges. The average length of stay for patients
was 4 days. The psychiatric CL is available for all admit-
ted patients. The physicians or PAs request CL services
via a consultation order entered in the electronic med-
ical record. Nurses can also identify the need for CL
services; in these situations, the nurse contacts the
physician or the PA on the team who places the order
for CL services. Consultations are typically seen within
4 to 8 h of placement, depending upon the acuity and
time sensitivity of the requested consult. Non-urgent
consults may be seen the next day if the caseload is
high. For the purposes of this study, a separate CL
order and group of practitioners were put in place that
would only offer the MI interview.
Participants
Participants will be providers (physicians, PAs, nurses)
and inpatients who are using tobacco or illicit drugs or
misusing alcohol or prescription medications.
Inclusion criteria for provider participants are (1) as-
signment to one of the general medical inpatient units;
and (2) agreement to all study procedures. Providers will
be excluded if they (1) only work on intensive care units
where patient morbidity would bypass interviewing; (2)
have been formally supervised in MI in the past; or (3) in-
tend to give notice to leave the hospital or are scheduled
for medical or family leave during the study period.
Inclusion criteria for inpatient participants are as fol-
lows: (1) 18 years of age or older; (2) acknowledge use of
drugs, alcohol, or nicotine within the past 28 days and
meet screening criteria consistent with a substance use
disorder; (3) have an expected length of stay of 2–3 days;
and (4) willing to consent to audio recording of the MI
session, should it occur. Patients will be excluded if they
(1) have an altered mental status such as delirium,
encephalopathy, dementia, or mental retardation that
would impair provision of consent and ability to partici-
pate; (2) are unable to speak English; (3) are placed in an
intensive care unit bed; (4) were previous study partici-
pants; and (5) have any other medical condition that in-
vestigators feel would make it too difficult to complete
an assessment and MI interview (e.g., stroke, deafness,
tracheostomy).
Provider screening, recruitment, randomization, and
reimbursement
The main unit of randomization will be the providers
within the hospitalist service. The service includes physi-
cians, PAs, and nurses who work on non-critical care gen-
eral medical units. Prior to randomization, members of
the study team will meet with the providers during staff
meetings, wherein they will describe the project and elicit
interest. Thereafter, interested providers will be screened
for eligibility, give written informed consent for their par-
ticipation, and complete baseline assessments. Following
baseline assessments, a restricted randomization proced-
ure generated by the study’s data manager will be used to
allocate an equal number of providers to the three condi-
tions (10 providers per condition); allocation will be con-
cealed from all other research staff until condition
assignment. Participants will be reimbursed $350 and
eight CME credits for baseline assessments and workshop
training and $50.00 for post-trial assessments.
MI intervention
The practice under study for implementation is a single
20-min MI session used to train medical students and phy-
sicians [71, 72]. The MI session is based on the four main
processes of MI [16]: (1) engage the patient to understand
his/her substance use and motivations for change; (2) focus
on the primary problematic substance; (3) evoke change
talk and resolve sustain talk about the patient’s substance
use; and (4) plan for change by developing a change plan
or present change options for later consideration.
Implementation conditions
Providers will each receive the MI implementation
strategy offered within their assigned condition. Ini-
tially, providers will receive MI workshop training.
They will be randomized to an implementation condi-
tion immediately upon completion of the workshop. In
each implementation condition, all providers, as well as
the CL clinicians in Order One, will audio record their
MI interviews to confirm the interviews have occurred
and to permit MI integrity rating.
Workshop only (See One)
Providers will participate in a 1-day skill-building work-
shop conducted by the first author (SM), a member of the
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Motivational Interviewing Network of Trainers (MINT),
according to MINT recommendations, giving them an
opportunity to “see” the MI intervention and learn how
to conduct it through expert and video demonstrations
and experiential activities. Providers will also be taught
how to screen patients for risky substance use with the
modified CAGE for alcohol and drugs [73] and Heaviness
of Smoking Index [74].
Workshop plus live supervision (Do One)
Providers will participate in a 1-day skill-building work-
shop, as outlined above. Following the workshop, the
providers will each “do one” MI intervention under the
live “bedside” supervision of a CL clinician trained in
MI. The study’s first author (SM) will have taught four CL
clinicians MI and the accompanying supervisory practices
developed in prior MI training work [69, 71, 72]. Providers
will be supervised twice before beginning the trial and
once midstream. In addition, they can request additional
live supervision at any point during the trial, consistent
with the apprenticeship model [54–57].
Workshop plus consultation-liaison service (Order One)
Providers will participate in a 1-day skill-building work-
shop, as outlined above. They will be instructed that they
may either administer MI or “order” a MI interview to be
delivered by a CL clinician with specialty MI training.
Only providers in Order One may “order” a MI interview.
We will have four CL clinicians available for ordered MI
to provide adequate coverage.
Training CL clinicians in MI will follow a clinical trial
training approach used in efficacy and effectiveness trials
[75, 76]: (1) a 2-day skill-building workshop; (2) post-
workshop supervised practice cases based on review of
audio-recorded sessions; and (3) follow-up monthly group
supervision to maintain and monitor the CL clinicians’ MI
practice.
Patient screening, recruitment, and reimbursement
Research staff will review a list of patients newly admit-
ted to the general medical hospitalist service and
assigned to one of the provider participants, approach
patients not obviously excludable, explain the study pro-
cedures, and obtain verbal and written consent for
screening. Patients who provide consent will complete a
brief demographic questionnaire and be screened for (1)
delirium; (2) alcohol, drug, or nicotine use within the
past month; and (3) sufficient symptoms associated with
their substance use. After screening eligibility is con-
firmed, patients will be consented and complete a com-
puter intake that includes questions to self-identify the
primary substance misused, addiction severity, depres-
sion symptoms, and functional health. Finally, they will
be told that a provider may approach them on the unit
to discuss their use of substances, which would be audio
recorded as part of the study. Patient participants will be
reimbursed $30 for their assessment, whether or not
they ultimately receive MI.
Procedures for monitoring audio recording of MI
interventions
Providers will not be informed about which patients are
consented by research staff. Providers must rely on usual
procedures (e.g., notes in patients’ electronic medical re-
cords) and their workshop training to identify risky sub-
stance use and the need for MI. All providers will be
issued a digital recording device. They will audio record
their own MI sessions and give the recordings to re-
search staff, along with identifying information that will
enable the research staff to check the patients’ study en-
rollment status. If recordings are obtained from non-study
participants, they will be immediately erased by research
staff. Otherwise, they will be downloaded for storage on a
secure server for later analysis. Research staff will send oc-
casional messages to providers to remind them to record
their MI interventions. As a back-up, additional recording
devices will be conveniently placed on the units, and the
administrative assistant on the CL service and research
staff will have additional recording devices that can be
given to providers on demand.
Assessments
The proposed project will evaluate training effects
using mixed methods to gather both quantitative and
qualitative data [77, 78] and be organized according to
the basic structure of Kirkpatrick’s four-level (reaction,
learning, behavior, results) training evaluation model
[79]. Only instruments central to our primary and sec-
ondary outcomes or that are less familiar are described
in more detail. Provider assessments will occur at base-
line, during the trial, and post-trial (i.e., after their 40th
assigned study-enrolled patient has been discharged
from the unit). Patient assessments will occur only at
baseline.
Reaction level (reactions to implementation strategies)
The Workshop Evaluation Form and Supervision Evalu-
ation Forms [69, 80] will evaluate the providers’ satisfac-
tion with the workshops and supervision provided in the
study. A Facilitators and Barriers Qualitative Interview
will be used to assess the providers’ perception of the fa-
cilitators and barriers of screening patients for substance
use, intervening with them, specifically using MI, and
employing the different implementation strategies at
baseline and post-trial. Focus group or individual inter-
views will be conducted with providers as they enter and
exit the study. Key informant interviews will be con-
ducted with the Director of Hospitalist Services, the
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Chief PA, and nurse unit managers to further assess
organizational barriers and facilitators.
Learning level (changes in knowledge and attitudes)
Beliefs about MI [81] will assess the providers’ personal
experiences with and beliefs about MI and perceived
barriers to implementing it. The Motivational Interview-
ing Questionnaire [71] assesses the providers’ knowledge
of MI principles. Clinician Rulers [71] assesses the pro-
viders’ interest, confidence, and commitment in using MI.
Behavior level (changes in behavior)
MI uptake will be based on the number of MI interven-
tion sessions audio recorded by providers. The Inde-
pendent Tape Rater Scale (ITRS) will assess the integrity
of MI delivery and the criterion level of adequate MI
performance within each session collected at baseline
and during the trial. The ITRS includes items that cover
therapeutic strategies that are MI consistent (e.g., reflec-
tions) or inconsistent (e.g., unsolicited advice). For each
item, raters evaluate the practitioners for adherence
(i.e., the extent of intervention delivery) and compe-
tence (i.e., the skill/quality of intervention delivery)
along 7-point Likert scales. For our primary outcomes,
we will (1) calculate mean adherence and competence
scores for the two factors (fundamental and advanced
MI strategies) identified in prior psychometric analyses
[80, 82, 83]; and (2) determine if sessions achieve our
criterion level for adequately performing MI [66–68],
namely, at least half the MI consistent items rated aver-
age or above for both adherence and competence.
Result level (results that occurred from the application of
the new practice)
Motivational Interviewing Skills Code 2.1 Client Language
Coding System [84] will obtain frequency counts and
strength indices of positive (change talk) and negative
(sustain talk) language categories in four categories:
reason (includes desire, ability, and need statements as
subcategories); others (hypothetical advice to others, if-
then statements about the possibility of changing, fore-
telling of future problems if change does not occur,
problem recognition); taking steps; and commitment.
Provider, patient, and work environment characteristics
The Clinician Survey [85] will be used to collect baseline
provider demographics and background. For patients,
several instruments will be used: (1) Confusion Assess-
ment Method—Shortened Version [86] to assess delir-
ium symptoms seen at bedside; (2) Timeline Followback
[87, 88] to assess patients’ past month self-reported sub-
stance use; (3) modified Mini-International Neuro-
psychiatric Inventory Clinician-Rated [89] to generate
patient DSM 5 drug, alcohol, and nicotine use symptoms
and diagnoses; (4) sections of the Addiction Severity
Index [90] to assess the frequency, duration, and severity
of substance use problems over the patients’ lifetime and
in the past 30 days; (5) Patient Health Questionnaire—9
[91] to determine severity of depression; (6) Short Form
Health Survey—12 [92] to measure patients’ functional
health; (7) Medical Chart Review to obtain length of stay
on the unit, admission and discharge diagnoses, con-
firmation of self-reported substance misuse (e.g., labs),
and possible barriers to receipt of MI that may occur
after consent or assessment (e.g., onset of delirium, car-
diac arrest, early release from hospital); and (8) Motiv-
ation for Change Scale [93, 94], which uses three items
(analog scale coded from 1 to 100) tapping patient drug,
alcohol or tobacco use likelihood, problem recognition,
and treatment motivation. Finally, the Nursing Work
Index-Revised [95–97] was used, a 15-item scale to ac-
cess provider perception of the hospitalist service work
environment in terms of (1) autonomy in making patient
care decisions; (2) control providers have over others to
promote high-quality patient care; (3) collegiality with
other medical staff; and (4) administrative/managerial
support.
Cost estimates
We will estimate the costs of the three MI implementa-
tion strategies from the perspective of the provider (i.e.,
hospital) to increase the real-world usefulness of the cost
estimates outside of this research protocol [98]. We will
not include research costs (e.g., participant reimburse-
ments) but rather restrict cost estimates to those associ-
ated with implementing the three MI implementation
strategies. Our cost methodology will follow the micro-
costing steps recommended by Yates [99] and Zarkin
and colleagues [100]. We will first delineate relevant
non-research activities (e.g., MI workshop training, MI
interventions, supervision (including expert review of
CL provider sessions)), and, for each identified activity,
we will gather data on both the time spent by personnel
in the activities and, as relevant, the space associated
with each activity using a modified version of the Re-
source Allocation Worksheet developed for Project
COMBINE [98]. This form will collect data on the total
labor hours spent on each activity by the trainer, pro-
viders, and CL clinicians and the space used to conduct
the activity. The labor costs of each activity will be equal
to the product of the amount of time spent by each per-
son on the activity and their fully loaded wage (i.e., in-
cluding fringe and overhead). To estimate space costs,
the research assistant will measure in square feet the size
of the rooms used for training, MI interventions, and
supervision. We will calculate an average space estimate
per medical unit for the main activity domains (workshop
training, MI intervention, supervision) and multiply these
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domains by the annual rent per square foot for the hos-
pital. We will obtain salary data (actual wage plus fringe
rate for salary staff and hourly contract rate for contract
staff ) for providers and CL clinicians and annual rent per
square foot from administrators. We also will record all
the direct material expenses (e.g., rating forms, recording
devices) of conducting the MI training workshops and
supervisions.
Data analyses
Data analysis for quantitative primary and secondary
outcomes
Descriptive statistics for all outcome variables will be
calculated prior to statistical analysis. Continuous out-
come variables will be evaluated for normality and trans-
formations will be applied as necessary. Two-sided tests
and overall alpha level of 0.05 for all primary hypotheses
will be used.
The principal strategy for assessing the effectiveness of
the study implementation conditions on outcome will be
mixed effects general linear models for continuously
measured primary (percentage MI sessions conducted,
MI adherence, and competence) and secondary (strength
and frequency of patient change and sustain talk) out-
comes variables, and generalized linear mixed models
for binary outcomes (e.g., meets criterion MI perform-
ance threshold). In both types of models, we will have
training condition as the main predictor variable and
will include random effects for providers to account for
clustering of observations within providers. Our main
hypotheses involve group comparisons with the See
One group as the reference condition. We will consider
significant comparisons of the Do One and Order One
conditions to the See One condition in the predicted
direction (e.g., more MI sessions conducted) as supportive
of our hypotheses. Comparisons of Do One with Order
One conditions will be conducted for exploratory
purposes only.
Adequacy of sample size for primary hypotheses
Based on prior meta-analyses [41, 42, 101], we conserva-
tively assume medium effect sizes for between-group
comparisons. Intra-class correlations accounting for ex-
pected within clinician variance were estimated based on
Imel et al. [102] and are expected to be small (in the 0.05
to 0.10 range). Feasibility constraints (i.e., 10 providers per
condition) limited the number of provider clusters being
considered. Finally, because we do not expect all providers
to identify substance using patients and use MI with them
(i.e., our first hypothesis about MI uptake), we will require
a larger sample size of study-enrolled patients to reach
our targeted number of audio-recorded MI sessions for
hypothesis testing purposes. We estimate 80 % of patients
across conditions will receive MI. Based on these esti-
mates and constraints, alpha level of 0.05 and power of
80 %, 30 providers and 40 patients per provider will be
sufficient for testing the primary hypotheses of the study
in this cluster-randomized implementation trial. Table 1
shows the actual total sample size for the cluster-
randomized design for continuous and binary outcomes,
adjusted for a conservative estimate of MI uptake.
Incremental cost-effectiveness analyses
The relative cost-effectiveness of the three MI implemen-
tation strategies will be assessed using both incremental
cost-effectiveness ratios (ICERs) and cost-effectiveness ac-
ceptability curves (CEACs). Incremental cost-effectiveness
analysis is the appropriate approach to use in this study
inasmuch as Do One and Order One both add clear and
certain costs to See One [103, 104]. ICERs and CEACs
will be calculated from the provider’s (i.e., hospital)
perspective. Using the cost estimates described in the
Assessments subsection, we will calculate ICERs for
multiple outcome measures, including (1) the number
of MI sessions delivered and (2) the number of MI
sessions delivered to criterion. The ICERs measure the
incremental cost of using a given integration strategy,
compared to the next-least-costly strategy, to produce
an extra unit of effect for each of the outcomes. By
using multiple outcomes, we can determine the robust-
ness of our cost-effectiveness findings and provide a
more fine-grained cost-effectiveness analysis to address
different priorities (e.g., uptake of MI by providers on
medical units, integrity of MI delivered to patients) that
stakeholders may have [105, 106].
To illustrate the uncertainty associated with the ICER
point estimates, costs and effects for each implementa-
tion strategy will be bootstrapped (with 2000 replicates)
to produce confidence intervals around the ICERs and
to produce CEACs for each of the outcome measures
[107]. CEACs quantify the uncertainty in the cost-
effectiveness analysis by showing the probability that
each strategy is the most cost-effective for any given
threshold value [107–109]. Finally, both scenario-based
Table 1 Sample size estimates based on two-sided alpha = 0.05 for pairwise condition comparisons and 80 % power
Effect size Total sample size for





Total sample size for a
cluster RCT unadjusted
for estimated MI uptake
Total sample size for
a cluster RCT adjusted
for estimated MI uptake
d = 0.4 300 0.07 31 31 930 1116
40 vs 18 % 195 0.1 30 17 510 765
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analysis (i.e., likely case, best case, worst case) and one-
way sensitivity analysis will be conducted to determine
the robustness of the cost-effectiveness results to alter-
native assumptions about a wide variety of implementa-
tion parameters (e.g., unit costs of labor, space, and
materials). The results of the one-way sensitivity analysis
will be presented graphically using a tornado diagram.
Qualitative data analyses
Each focus group and key informant interview will be
audio recorded, transcribed, and independently coded
using debriefing to discuss and challenge findings [110].
Grounded theory methods developed by Strauss and Cor-
bin [111, 112] will be used to identify themes related to
implementation facilitators and barriers across informants.
The collection of data from multiple informants, iterative
process of data collection and analysis, use of two re-
searchers to code each transcript and work to consensus,
keeping an audit trail of the data analysis process, and the
theoretical sampling of themes and concepts will increase
creditability, transferability, dependability, and confirm-
ability of the findings [110]. We will identify the barriers
and facilitators that are unique to and common across the
conditions.
Ethics
The study received approval from the Yale University
Human Research Protection Program’s Human Investi-
gation Committee and is registered at ClinicalTrials.gov
(NCT01825057).
Trial status
At the time of submission, the research team had re-
cruited 30 clinicians and 813 patients. However, seven
providers dropped out of the study before completing the
trial (i.e., before reaching 40 opportunities to identify study
patients and deliver MI) secondary to relocation, promo-
tion, or re-assignment. These providers will be replaced to
preserve the integrity of the randomized clustered study
design, and as a result, recruitment will exceed the original
targets of 30 providers and 1200 patients. Recruitment is
ongoing and estimated to continue until January 2017.
Discussion
This study will determine if two strategies commonly
used to implement interventions with medical inpatients
(Do One, Order One) are effective for integrating sub-
stance use treatment into general medical inpatient
units, beyond the effects of traditional CME workshops
(See One). The apprenticeship model represented by
Do One is highly compatible with how medical providers
learn new techniques following initial educational activ-
ities. However, medical providers may believe conducting
behavioral interventions for substance use is outside their
scope of practice, too difficult to perform well, or incom-
patible with their workflow and busy schedules. Alterna-
tively, using CL allows them to “order” psychiatry staff to
provide MI, making their task of providing critical addic-
tion interventions to substance-using inpatients easier.
However, if medical providers do not think addressing
addictive behavior is central to their role, they may not
actively screen patients for substance use or place an order
for CL to deliver MI. Identifying how well each of these
implementation strategies work, what factors facilitate or
impede their use, and how much they cost will help in-
form future efforts to implement evidence-based addiction
treatment services in medical hospitals.
Limitations
The study is being conducted at only one large academ-
ically affiliated teaching hospital, which may limit the
generalizability of its findings and disallow the examin-
ation of organizational differences (e.g., organizational
readiness for change) that could influence the imple-
mentation outcomes [113]. Nonetheless, the study will
assess the providers’ perception of their work environ-
ment (e.g., administrative/managerial support), which
may point to some organizational factors that might
affect MI uptake and its integrity. In addition, the study
is not tracking patient substance use outcomes or mea-
sures of health care utilization (e.g., ER visits, rehospitali-
zations) and instead relies on proximal patient outcomes,
namely, the frequency and strength of in-session patient
change and sustain talk. Finally, this study only will follow
the extent to which providers use MI during the trial and
does not include a follow-up phase that assesses the sus-
tainability of their practice. Should the Do One or Order
One strategies prove to be more effective and cost-
effective than See One, future studies should include a
post-trial phase in which the sustainability of MI practice
is measured.
Conclusion
The profound cost and deleterious consequences of sub-
stance use dictate that evidence-based addiction treat-
ments are made available to patients at all levels of the
health care system. Inpatient medical hospitals serve as a
catch bin for a large proportion of patients whose risky,
hazardous, or disordered substance use drives or compli-
cates their medical conditions. The extent to which differ-
ent implementation strategies can effectively and cost-
effectively help inpatient medical providers capitalize on
this teachable moment requires careful scrutiny.
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